The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Stocks at record high but yields fall, dollar under pressure

Fri, 27th Nov 2020 20:02

* Highly anticipated vaccine facing more scrutiny

* Treasury yields fall, point to lingering COVID-19 worries

* Bitcoin extends Thursday's big losses

* USD index closes at 2-1/2 year low

* U.S. markets on shortened hours after Thanksgiving holiday

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh
(Updates to U.S. market close)

By Rodrigo Campos

NEW YORK, Nov 27 (Reuters) - Stocks rose across the globe on Friday to close
at a fresh high and remained on track for their strongest monthly performance on
record but the Nasdaq outperformed on Wall Street and Treasury yields fell,
indicating lingering concerns over rising coronavirus cases globally.

A global stock index touched a record high for the third session this week
while the dollar index, a measure of the greenback versus six peers, touched a
three-month low and closed at its lowest since April 2018.

On Wall Street, the main indexes rose and the Nasdaq Composite hit a record
high. The Nasdaq outperformance mirrors recent sessions when, despite rising
stocks, the focus was on the economic impact of the pandemic. The U.S. expects a
further surge in coronavirus infections following the Thanksgiving holiday.

The Dow Jones Industrial Average rose 37.9 points, or 0.13%, to
29,910.37, the S&P 500 gained 8.7 points, or 0.24%, to 3,638.35 and the
Nasdaq Composite added 111.44 points, or 0.92%, to 12,205.85.

European stocks rose after the European Central Bank reinforced expectations
of further stimulus next month and Sweden's Riksbank made a surprise increase to
its quantitative-easing program.

The pan-European STOXX 600 index rose 0.41% and MSCI's gauge of
stocks across the globe gained 0.39% to 623.75 after touching a
high of 624.29.

Emerging market stocks rose 0.12%, while Japan's Nikkei rose 0.40%.

Questions also lingered over trial data on AstraZeneca's COVID-19
"vaccine for the world," as several scientists sounded caution over the trial
results.

Australian shares ended down 0.5% with Treasury Wine Estates
down 11.25% as China imposed new tariffs on Australian wine, the latest
move in the countries' long-running trade row.

The European Union and Britain said substantial differences remained over a
Brexit trade deal, as the EU chief negotiator prepared to travel to London in a
last-ditch attempt to avoid a tumultuous finale to the five-year crisis.

Sterling, which has climbed over 3% against the dollar this month, was last
trading at $1.3299, down 0.42% on the day.

"Clearly, there are substantial and important differences still to be
bridged, but we're getting on with it," British Prime Minister Boris Johnson
told reporters.

The dollar index fell 0.269%, with the euro up 0.39% to
$1.196. The Japanese yen strengthened 0.24% versus the greenback at 104.03 per
dollar.

"Over the longer term, this is probably the right trend for the dollar. We
think the dollar has further room to the downside," said Bipan Rai, North
America head of foreign exchange strategy at CIBC Capital Markets.

The yield on benchmark Treasury notes fell as some investors
sought the safety of holding government debt over persistent concerns about the
surge in coronavirus cases and lockdowns in several U.S. states and around the
world.

The 10-year notes last rose 11/32 in price to yield 0.8422%, from 0.878%
late on Wednesday.

Oil prices, up for a fourth straight week, were mixed.

U.S. crude recently fell 0.42% to $45.52 per barrel and Brent
was at $48.27, up 0.98% on the day. Both rose over 7% this week.

Bitcoin fell 2.25% to $16,774.49 after tumbling 8.4% in the
previous session. The cryptocurrency brushed against its record high of $19,666
earlier this week and has rallied around 130% this year.

Spot gold dropped 1.3% to $1,787.40 an ounce. Silver fell
3.20% to $22.70.

(Reporting by Rodrigo Campos; additional reporting by Sinéad Carew in New York,
Marc Jones in London and Shivani Kumaresan in Bengaluru
Editing by Nick Zieminski
)

More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.